Scientists probe why common heart treatment fails in genetic condition
NCT ID NCT07454135
Summary
This study aims to understand why atrial fibrillation (an irregular heartbeat) is more common and harder to treat in people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle is abnormally thick. Researchers will study 40 adults with both conditions who are already scheduled for a standard heart procedure, using detailed heart scans and electrical measurements. The goal is to gather knowledge that could lead to better future treatments, not to test a new therapy on participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.